Vitamin B12 identified as the inhibitor of a key enzyme in hereditary Parkinson's disease

Vitamin B12 significantly prevents the neurotoxicity of LRRK2 genetic variants associated with hereditary Parkinson's disease. The findings may help with the development of new therapies to combat the neurodegenerative disease.